Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIqgeo Regulatory News (IQG)

Share Price Information for Iqgeo (IQG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 467.00
Bid: 462.00
Ask: 472.00
Change: 0.00 (0.00%)
Spread: 10.00 (2.165%)
Open: 467.00
High: 467.00
Low: 467.00
Prev. Close: 467.00
IQG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

12 Nov 2015 07:00

RNS Number : 4315F
Ubisense Group PLC
12 November 2015
 

12.11.15

 

Ubisense Group PLC (the "Company")

 

Trading Update

 

Ubisense ("Ubisense" or the "Company") (LON:UBI), a market leader in enterprise location intelligence solutions, announces an update on current trading and an outlook for the current financial year ending 31 December 2015 ("FY15").

 

The Geospatial division has continued to trade satisfactorily. There is some significant deal concentration weighted towards the final weeks of FY15, in addition there is a good pipeline of opportunities to close for both FY15 and 2016. During the period the Company deployed with a number of its strategic partners, demonstrating ongoing demand for its solutions as well as validating its partner channel approach.

 

The RTLS division has been materially impacted by the recent well-publicised challenges facing the Company's large automotive customers, in Germany especially, and this has resulted in the downscaling, delay or cancellation of certain major deployment contracts and a likely lengthening of customer decision cycles in the wider industry.

 

Due to these unforeseen circumstances, there is a risk of a material revenue and subsequent profit shortfall against previous guidance for FY15. The Board's estimate is that second half revenues will now be in the range of £12.6-14.6 million (as against first half revenues of £10.4 million) and that full year FY15 revenues will therefore be in the range of £23-25 million. This range of outcomes should result in at least a small positive adjusted EBITDA for the second half, before non-recurring costs, but an adjusted EBITDA loss for the full year FY15.

 

As previously announced and as part of the stated strategic restructuring, the Board implemented some significant cost reduction initiatives early in the second half, resulting in annualised savings of £2.0 million. Given the challenging trading conditions highlighted above, the Board has decided to implement further cost actions over the coming months, with a view to achieving further annualised savings of approximately £3 million. A further exceptional charge of £1.7 million is expected in the second half of FY15 in relation to these measures, bringing the total exceptional charge in FY15 to £3.6 million.

 

Cash conversion this year has been adversely affected by restructuring costs and extended payment terms on certain contracts, impacting the collection of receivables. Gross cash at the end of October 2015 was £4.8 million, with £5.3 million drawn under the Company's available debt facilities, giving a net debt position of £0.5 million. The Company expects to remain in a gross cash, but net debt position, as at 31 December 2015. Management is in regular dialogue with its principal lender, HSBC, who remain supportive and in constructive discussion to support the Company's on-going requirements. The Board is determined to ensure that the Company's cash outflow situation is rectified though improved cash conversion in 2016, coupled with the benefits of the recent and current cost alignment initiatives.

 

Peter Harverson, Chairman designate, commented:

 

"The second half of the period has been challenging for the business, driven by macro events outside of our control. Whilst disappointing to announce a reduced revenue number, the recent signing of a new automotive OEM in Spain through Atlas Copco and other strategic wins support the Board's view that the strategy in place means the Group is well positioned moving forward.

 

In the short-term, we have made some necessary decisions to right size the cost base of the business and are focused on refining our sales strategy, in particular our partner channel development, to drive revenue growth through expanded scale and reach."

 

Contact

Ubisense Group plc Tel: + 44 (0) 1223 535170

Richard Green

Tim Gingell

 

Numis Securities Limited  Tel: + 44 (0) 207 2601000

Simon Willis, Jamie Lillywhite (Corporate Finance)

Rupert Krefting (Corporate Broking)

 

Redleaf Communications   Tel: +44 (0) 20 7382 4730

Rebecca Sanders-Hewett, Richard Gotla,

David Ison, Harriet Lynch

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTPKDDBKBDBADD
Date   Source Headline
2nd Jan 20205:14 pmRNSTotal Voting Rights
24th Dec 20199:57 amRNSDirector's Dealing
16th Dec 20197:00 amRNSDirectors' Dealings
11th Dec 20197:00 amRNSDirectors' Dealings
6th Dec 201911:23 amRNSDirectors' Dealings
2nd Dec 20194:03 pmRNSDirector's Dealing
25th Nov 20191:25 pmRNSTR-1: Standard form notification of major holdings
25th Nov 20197:17 amRNSTR-1: notification of major holdings
25th Nov 20197:08 amRNSDirector's Dealings
18th Nov 20197:00 amRNSIQGeo customer signs USD1.2 million in contracts
31st Oct 201910:22 amRNSDirectorate Changes
10th Oct 20197:00 amRNSIQGeo selected by a major Japanese power provider
30th Sep 20197:00 amRNSInterim results
16th Sep 20193:04 pmRNSTR-1: notification of major holdings
13th Sep 20193:10 pmRNSTR-1: notification of major holdings
12th Sep 20197:41 amRNSTR-1: notification of major holdings
11th Sep 20191:16 pmRNSTR-1: notification of major holdings
10th Sep 20194:54 pmRNSTR-1: notification of major holdings
4th Sep 201912:07 pmRNSTR-1: notification of major holdings
3rd Sep 20193:17 pmRNSTR-1: Notification of major holdings
3rd Sep 20193:08 pmRNSDirector Dealings
2nd Sep 20195:50 pmRNSResult of Tender Offer and Total Voting Rights
22nd Aug 20191:18 pmRNSResult of General Meeting
7th Aug 20197:00 amRNSFiling of Unaudited Balance Sheet
2nd Aug 20197:00 amRNSAnnouncement of Tender Offer and General Meeting
1st Aug 20194:45 pmRNSChange in Director's Interests
31st Jul 20197:00 amRNSTrading update
26th Jul 20195:16 pmRNSTR-1: Standard notification form of major holdings
1st Jul 20197:00 amRNSBlock listing six monthly return
21st Jun 20197:00 amRNSDirectorate Change
5th Jun 20191:05 pmRNSStandard form for notification of major holdings
5th Jun 201912:57 pmRNSResult of Annual General Meeting
10th May 20197:00 amRNSPosting of the Notice of AGM
1st May 20197:00 amRNSPosting of Annual Financial Report
11th Apr 20197:00 amRNSAnnual Financial Report
8th Mar 20197:00 amRNSTR-1 notification of major holdings
6th Mar 20197:00 amRNSTotal Voting Rights
19th Feb 20197:00 amRNSBlock listing extension
14th Feb 20197:00 amRNSStatement re Chairman
31st Jan 20197:00 amRNSTrading update
2nd Jan 20197:00 amRNSBlock listing six monthly return
31st Dec 201810:09 amRNSStatement re sale of division
18th Dec 20187:00 amRNSUpdate on Sale of RTLS SmartSpace
13th Dec 20189:58 amRNSResult of General Meeting
23rd Nov 20181:51 pmRNSHolding(s) in Company
23rd Nov 20181:10 pmRNSHolding(s) in Company
21st Nov 20189:05 amRNSSecond Price Monitoring Extn
21st Nov 20189:00 amRNSPrice Monitoring Extension
21st Nov 20187:00 amRNSProposed Sale of RTLS SmartSpace for up to £35.0m
20th Nov 20182:05 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.